ArticlemedRxiv : the preprint server for health sciences2025
Long-term mortality outcomes among immunotherapy recipients treated with dupilumab for the management of cutaneous immune-related adverse events.
Sara Khattab et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.